TREAT-NMD ALLIANCE LTD
Treat NMD exists to accelerate treatments to patients with neuromuscular disease, by engaging withpatient advocacy groups, researchers, clinicians, industry and regulators to advance treatments and sharebest practice.
Financial health, per its FY2024 accounts
The accounts state that the group reported a net movement in funds of £(39,364) for the year, resulting in total unrestricted reserves of £837,146. The trustees confirm that the group has adequate resources to continue in operational existence for the foreseeable future, with no material uncertainties identified regarding going concern. The charity's own reserves policy is described as building levels to support objectives, with current reserves standing at £9,643 for the parent charity.
What the accounts disclose
“Other trading activities 5 1,999,150”
“The reserves policy for TREAT-NMD Alliance Limited continues to be building levels to support the charity’s objectives.” — page 7
“During the year honorarium payments totalling £734 (2023: £1,500) were paid to J Dowling, trustee, for attendance at TACT meetings.” — page 33
“During the year, payments of £27,232 (2023: £18,666) were paid to Muscular Dystrophy Association USA, a charity in which S Hesterlee has signifcant influence, in relation to a gene therapy masterclass.” — page 33
“During the year honorarium payments totalling £734 (2023: £1,500) were paid to J Dowling, trustee, for attendance at TACT meetings.” — page 33
“During the year, payments of £27,232 (2023: £18,666) were paid to Muscular Dystrophy Association USA, a charity in which S Hesterlee has signifcant influence, in relation to a gene therapy masterclass.” — page 33
“During the year honorarium payments totalling £734 (2023: £1,500) were paid to J Dowling, trustee, for attendance at TACT meetings.” — page 33
“During the year, payments of £27,232 (2023: £18,666) were paid to Muscular Dystrophy Association USA, a charity in which S Hesterlee has signifcant influence, in relation to a gene therapy masterclass.” — page 33
“During the year honorarium payments totalling £734 (2023: £1,500) were paid to J Dowling, trustee, for attendance at TACT meetings.” — page 33
“During the year, payments of £27,232 (2023: £18,666) were paid to Muscular Dystrophy Association USA, a charity in which S Hesterlee has signifcant influence, in relation to a gene therapy masterclass.” — page 33
“During the year honorarium payments totalling £734 (2023: £1,500) were paid to J Dowling, trustee, for attendance at TACT meetings.” — page 33
“During the year, payments of £27,232 (2023: £18,666) were paid to Muscular Dystrophy Association USA, a charity in which S Hesterlee has signifcant influence, in relation to a gene therapy masterclass.” — page 33
Corporate structure
- Registered company of the charity Companies House 12099857
Company officers (Companies House)
- VONROSEN, Robert not on trustee list
- WAGNER, Kathryn Rae, Dr on trustee list
- STRAUB, Volker Wilhelm, Dr on trustee list
- ALLISON, David
Structured financials (annual return, FY ending 31/07/2024)
Trustees
- Dr Kathryn Wagnerchair
- Prof and Dean Kanneboyina Nagaraju
- Robert von Rosen
- Volker Wilhelm Straub
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/07/2024 | £2.5m | £2.5m |
| 31/07/2023 | £2.2m | £1.9m |
Common questions
Is TREAT-NMD ALLIANCE LTD financially healthy?
Per its FY2024 accounts: The accounts state that the group reported a net movement in funds of £(39,364) for the year, resulting in total unrestricted reserves of £837,146. The trustees confirm that the group has adequate resources to continue in operational existence for the foreseeable future, with no material uncertainties identified regarding going concern. The charity's own reserves policy is described as building levels to support objectives, with current reserves standing at £9,643 for the parent charity. Its FY2024 accounts were audited by UNW LLP.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| CBRE UK CHARITABLE TRUST | 4 | £4k |
| The Patricia Routledge Foundation | 3 | £23k |
| PILKINGTON CHARITIES FUND | 3 | £22k |
| FRAZER TRUST | 3 | £18k |
| THE WILLIAM ALLEN YOUNG CHARITABLE TRUST | 3 | £15k |
| CHARLES S FRENCH CHARITABLE TRUST | 3 | £14k |
| THE W E DUNN TRUST | 3 | £6k |
| DORIS FIELD CHARITABLE TRUST | 3 | £4k |
Charities like this
- THE NEUROLOGICAL ALLIANCE
- MYOTUBULAR TRUST
- Spinal Muscular Atrophy UK
- NEUROMUSCULAR CENTRE
- MUSCULAR DYSTROPHY GROUP OF GREAT BRITAIN AND NORTHERN IRELAND
- MOTOR NEURONE DISEASE ASSOCIATION
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| TREAT-NMD ALLIANCE LTD | £2.5m | — | — | unclear | — | no doubt |
| THE NEUROLOGICAL ALLIANCE | £297k | £70,001 - £80,000 | 1 | below | — | no doubt |
| MYOTUBULAR TRUST | £147k | £20,000 | 0 | unclear | — | no doubt |
| Spinal Muscular Atrophy UK | £1.6m | — | 0 | above | — | no doubt |
| NEUROMUSCULAR CENTRE | £1.4m | — | 0 | unclear | — | no doubt |
| MUSCULAR DYSTROPHY GROUP OF GREAT BRITAIN AND NORTHERN IRELAND | £7.9m | — | — | unclear | 40.4% | no doubt |